11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Serum disposition of sertraline, N-desmethylsertraline and paroxetine: A pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
(
- Contribution to journal › Article
-
Mark
Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
(
- Contribution to journal › Article
- 2003
-
Mark
Therapeutic Drug Monitoring of Racemic Citalopram: A 5-Year Experience in Sweden, 1992-1997.
(
- Contribution to journal › Article
- 2002
-
Mark
Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
(
- Contribution to journal › Article
-
Mark
Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
(
- Contribution to journal › Article
-
Mark
Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
(
- Contribution to journal › Article
- 1999
-
Mark
Guidelines for follow-up of women at high risk for inherited breast cancer : consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
(
- Contribution to journal › Article